{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:51:59Z","timestamp":1787068319864,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017908","name":"ALSAM Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017908","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.japh.2023.05.012","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T22:38:21Z","timestamp":1684363101000},"page":"1530-1538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and economic implications of increasing access to herpes zoster vaccination rate in community pharmacies"],"prefix":"10.1016","volume":"63","author":[{"given":"Alexandre H.","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajesh K.","family":"Veettil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-0752","authenticated-orcid":false,"given":"Lan My","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1962-066X","authenticated-orcid":false,"given":"Elizabeth","family":"Bald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1203-1782","authenticated-orcid":false,"given":"Casey","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7009-7907","authenticated-orcid":false,"given":"Nathorn","family":"Chaiyakunapruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.japh.2023.05.012_bib2","first-page":"e309","article-title":"Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges","volume":"19","author":"Taitel","year":"2013","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.japh.2023.05.012_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.japh.2023.05.012_bib6","article-title":"HP2020 Herpes Zoster Immunization Goal Has Been Met","volume":"88","author":"Wick","year":"2020","journal-title":"Pharmacy Times"},{"key":"10.1016\/j.japh.2023.05.012_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"10.1016\/j.japh.2023.05.012_bib8","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1186\/s12889-019-8044-y","article-title":"Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting","volume":"19","author":"Ecarnot","year":"2019","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.japh.2023.05.012_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/ICL.0000000000000041","article-title":"Improving adherence to national recommendations for zoster vaccination through simple interventions","volume":"40","author":"Elkin","year":"2014","journal-title":"Eye Contact Lens"},{"issue":"9","key":"10.1016\/j.japh.2023.05.012_bib10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.amjmed.2013.02.018","article-title":"Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record","volume":"126","author":"Otsuka","year":"2013","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.japh.2023.05.012_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1468-0009.12342","article-title":"Impact of pharmacists on access to vaccine providers: a geospatial analysis","volume":"96","author":"Shah","year":"2018","journal-title":"Milbank Q"},{"issue":"1","key":"10.1016\/j.japh.2023.05.012_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/21645515.2019.1637218","article-title":"The essential role of pharmacists facilitating vaccination in older adults: the case of Herpes Zoster","volume":"16","author":"Tak","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.japh.2023.05.012_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1331\/JAPhA.2013.12019","article-title":"Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies","volume":"53","author":"Wang","year":"2013","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2023.05.012_bib14","doi-asserted-by":"crossref","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.japh.2023.05.012_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jval.2012.06.012","article-title":"Modeling good research practices overview: a report of the ISPOR-SMDM modeling good research practices task Force-1","volume":"15","author":"Caro","year":"2012","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.japh.2023.05.012_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jamainternmed.2017.7431","article-title":"Cost-effectiveness of the adjuvanted herpes zoster subunit vaccine in older adults","volume":"178","author":"Le","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.japh.2023.05.012_bib17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.vaccine.2003.08.045","article-title":"The role of pharmacists in the delivery of influenza vaccinations","volume":"22","author":"Steyer","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.japh.2023.05.012_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11606-016-3844-6","article-title":"Determining the optimal vaccination schedule for herpes zoster: a cost-effectiveness analysis","volume":"32","author":"Le","year":"2017","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.japh.2023.05.012_bib24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.japh.2023.05.012_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993\u20132006: evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.japh.2023.05.012_bib26","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A\u00a0vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.japh.2023.05.012_bib27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1086\/514342","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"44","author":"Rothberg","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.japh.2023.05.012_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/00019053-200826020-00006","article-title":"Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness","volume":"26","author":"Prosser","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"16","key":"10.1016\/j.japh.2023.05.012_bib31","first-page":"352","article-title":"Centers for Disease Control and Prevention (CDC) Benefits from immunization during the vaccines for children program era-United States, 1994\u20132013","volume":"63","author":"Whitney","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.japh.2023.05.012_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1542\/peds.110.4.653","article-title":"Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis","volume":"110","author":"Zhou","year":"2002","journal-title":"Pediatrics"},{"issue":"23\u201324","key":"10.1016\/j.japh.2023.05.012_bib33","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","article-title":"The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales","volume":"19","author":"Edmunds","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.japh.2023.05.012_bib34","first-page":"344","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory","volume":"5","author":"Coplan","year":"2004","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.japh.2023.05.012_bib35","first-page":"67","article-title":"The role of community pharmacy-based vaccination in the USA: current practice and future directions","volume":"4","author":"Bach","year":"2015","journal-title":"Integr Pharm Res Pract"},{"issue":"4","key":"10.1016\/j.japh.2023.05.012_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.japh.2016.03.006","article-title":"The impact of pharmacist immunization programs on adult immunization rates: a systematic review and meta-analysis","volume":"56","author":"Baroy","year":"2016","journal-title":"J.\u00a0Am. Pharm. Assoc. (2003)"},{"issue":"47","key":"10.1016\/j.japh.2023.05.012_bib37","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2016.08.085","article-title":"Impact of pharmacists as immunizers on vaccination rates: a systematic review and meta-analysis","volume":"34","author":"Isenor","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.japh.2023.05.012_bib38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1331\/JAPhA.2009.08118","article-title":"Daily versus single-day offering of influenza vaccine in community pharmacies","volume":"49","author":"Grabenstein","year":"2009","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2023.05.012_bib39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1331\/JAPhA.2014.13118","article-title":"Influenza vaccination by pharmacists in a health sciences center: a 3-year experience","volume":"54","author":"Hagemann","year":"2014","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2023.05.012_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1331\/JAPhA.2012.10083","article-title":"Impact of a pharmacist immunizer on adult immunization rates","volume":"52","author":"Higginbotham","year":"2012","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2023.05.012_bib41","doi-asserted-by":"crossref","unstructured":"Page A, Harrison A, Nadpara P, Goode JR. Pharmacist impact on pneumococcal polysaccharide vaccination rates in patients with diabetes in a national grocery chain pharmacy. J Am Pharm Assoc (2003). 2020;60(3S):S51\u2013S55.e1.","DOI":"10.1016\/j.japh.2020.02.007"},{"issue":"3","key":"10.1016\/j.japh.2023.05.012_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.japh.2017.02.025","article-title":"Pharmacist impact on pediatric vaccination errors and missed opportunities in the setting of clinical decision support","volume":"57","author":"Wise","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.japh.2023.05.012_bib43","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.japh.2022.06.008","article-title":"The impact of pharmacist involvement on immunization uptake and other outcomes: an updated systematic review and meta-analysis","volume":"62","author":"Le","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2023.05.012_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1331\/154434506776180621","article-title":"Pharmacist involvement with immunizations: a decade of professional advancement","volume":"46","author":"Hogue","year":"2006","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"6","key":"10.1016\/j.japh.2023.05.012_bib45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1331\/JAPhA.2011.11544","article-title":"Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA\/AMCP stakeholder meeting","volume":"51","author":"Skelton","year":"2011","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2023.05.012_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.japh.2021.11.011","article-title":"Pharmacy technician-administered immunizations: a five-year review","volume":"62","author":"Adams","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2023.05.012_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1345\/aph.1D257","article-title":"Involvement of immunization-certified pharmacists with immunization activities","volume":"38","author":"Neuhauser","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.japh.2023.05.012_bib48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/pharmacy7040166","article-title":"Pharmacists as immunizers: the role of pharmacies in promoting immunization campaigns and counteracting vaccine hesitancy","volume":"7","author":"Bragazzi","year":"2019","journal-title":"Pharmacy (Basel)"},{"issue":"3","key":"10.1016\/j.japh.2023.05.012_bib50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.amepre.2018.05.011","article-title":"Clinicians\u2019 and pharmacists\u2019 reported implementation of vaccination practices for adults","volume":"55","author":"Lutz","year":"2018","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.japh.2023.05.012_bib51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.vaccine.2018.12.003","article-title":"The effect of a prescription order requirement for pharmacist-administered vaccination on herpes zoster vaccination rates","volume":"37","author":"Tak","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.japh.2023.05.012_bib53","author":"Winegarden"},{"issue":"1","key":"10.1016\/j.japh.2023.05.012_bib54","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.amepre.2015.06.008","article-title":"Influenza vaccination coverage among people with high-risk conditions in the U.S","volume":"50","author":"O'Halloran","year":"2016","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.japh.2023.05.012_bib55","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/21645515.2017.1403697","article-title":"An analysis of factors associated with influenza, pneumococcal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability","volume":"14","author":"La","year":"2018","journal-title":"Hum Vaccin Immunother"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912300153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912300153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:52:55Z","timestamp":1761544375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431912300153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S154431912300153X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.05.012","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and economic implications of increasing access to herpes zoster vaccination rate in community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}